Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

被引：0
|
作者：
Donald P. Tashkin
Nicola A. Hanania
Joe McGinty
Kimberly Denis-Mize
Imtiaz Chaudry
机构：
[1] David Geffen School of Medicine at UCLA,Division of Pulmonary and Critical Care Medicine
[2] Baylor College of Medicine,Division of Pulmonary and Critical Care Medicine
[3] Dey Pharma LP,undefined
来源：
Advances in Therapy | 2009年 / 26卷
关键词：
chronic obstructive pulmonary disease; formoterol; long-acting beta; agonist; maintenance therapy; nebulization; tiotropium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1024 / 1034
页数：10
相关论文
共 50 条
  • [1] Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease
    Tashkin, Donald P.
    Hanania, Nicola A.
    McGinty, Joe
    Denis-Mize, Kimberly
    Chaudry, Imtiaz
    ADVANCES IN THERAPY, 2009, 26 (11) : 1024 - 1034
  • [2] Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
    Welte, Tobias
    Miravitlles, Marc
    Hernandez, Paul
    Eriksson, Goran
    Peterson, Stefan
    Polanowski, Tomasz
    Kessler, Romain
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (08) : 741 - 750
  • [3] In COPD, Adding Nebulized Formoterol to Tiotropium Treatment Provides Added Benefits in Pulmonary Function, Dyspnea, and Rescue Medication Use: A Pooled Analysis.
    New, J.
    Hanania, N.
    Matovinovic, E.
    Tashkin, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [4] Erratum to: Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease
    Nicole Mittmann
    Paul Hernandez
    Carl Mellström
    Lance Brannman
    Tobias Welte
    PharmacoEconomics, 2011, 29 : 414 - 414
  • [5] Efficacy And Tolerability Of Budesonide/formoterol Added To Tiotropium Compared With Tiotropium Alone In Asian Patients With Severe Chronic Obstructive Pulmonary Disease
    Lee, S. -D.
    Xie, C. -M.
    Yunus, F.
    Itoh, Y.
    Su, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [6] Efficacy of budesonide/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease
    Feng, Jun-fei
    Ding, Guo-rong
    Xie, Yan-zhong
    Zhao, Dejun
    Wang, Xuehui
    MEDICINE, 2018, 97 (22)
  • [7] Tiotropium and the treatment of chronic obstructive pulmonary disease
    Anthonisen, Nick R.
    CANADIAN RESPIRATORY JOURNAL, 2007, 14 (08) : 460 - 462
  • [8] TREATMENT PERSISTENCE COMPARISON BETWEEN NEBULIZED FORMULATIONS OF ARFORMOTEROL AND FORMOTEROL IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Bollu, V
    Chen, Y. J.
    Makin, C.
    VALUE IN HEALTH, 2014, 17 (03) : A177 - A177
  • [9] Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
    Tashkin, Donald P.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 3105 - 3122
  • [10] Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
    Jayanthi, Nalini
    Krishnan, Karthickeyan
    Sudhir, Manali
    Girija, S.
    Nishi, P. A.
    Kumar, J. Sathish
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 28
12345